https://www.marketscreener.com/quote/stock/IDOGEN-AB-PUBL-107928966/news/Idogen-provides-update-on-timelines-for-the-development-of-the-tolerogenic-cell-therapy-IDO-8-31295097/?utm_source=telegram&utm_medium=social&utm_campaign=share